{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T10:45:21Z","timestamp":1771843521772,"version":"3.50.1"},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T00:00:00Z","timestamp":1351123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0048070","type":"journal-article","created":{"date-parts":[[2012,10,25]],"date-time":"2012-10-25T21:31:21Z","timestamp":1351200681000},"page":"e48070","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":31,"title":["Effects and Safety of Calcimimetics in End Stage Renal Disease Patients with Secondary Hyperparathyroidism: A Meta-Analysis"],"prefix":"10.1371","volume":"7","author":[{"given":"Qian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chuanming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,10,25]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ki.1997.297","article-title":"The hyperparathyroidism of chronic renal failure: a disorder of growth","volume":"52","author":"AM Parfitt","year":"1997","journal-title":"Kidney Int"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1056\/NEJM200005183422003","article-title":"Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis","volume":"342","author":"WG Goodman","year":"2000","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/10.supp3.13","article-title":"Renal osteodystrophy: pathogenesis and management","volume":"10","author":"EA Gonzalez","year":"1995","journal-title":"Nephrol Dial Transplant"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1093\/ajcn\/30.7.1064","article-title":"Actions of 1 alpha-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D3 on mineral metabolism in man. I. Effects on net absorption of phosphorus","volume":"30(7)","author":"AS Brickman","year":"1977","journal-title":"Am J Clin Nutr"},{"key":"ref5","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group (2009) KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl: S1\u2013130."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/366575a0","article-title":"Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid","volume":"366","author":"EM Brown","year":"1993","journal-title":"Nature"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1152\/physrev.2001.81.1.239","article-title":"Extracellular calcium sensing and extracellular calcium signaling","volume":"81","author":"EM Brown","year":"2001","journal-title":"Physiol Rev"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1124\/jpet.103.057273","article-title":"Pharmacodynamics of the type II calcimimetic compound cinacalcet HCl","volume":"308","author":"EF Nemeth","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1053\/j.ajkd.2006.01.015","article-title":"Meta-analysis of biochemical and patient-level effects of calcimimetic therapy","volume":"47","author":"GF Strippoli","year":"2006","journal-title":"Am J Kidney Dis"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Higgins JPT, Green S, Cochrane Collaboration (2008) Cochrane handbook for systematic reviews of interventions. Chichester, England; Hoboken, NJ: Wiley-Blackwell. xxi, 649 p.","DOI":"10.1002\/9780470712184"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"AR Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"820","DOI":"10.7326\/0003-4819-127-9-199711010-00008","article-title":"Quantitative synthesis in systematic reviews","volume":"127","author":"J Lau","year":"1997","journal-title":"Ann Intern Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"JP Higgins","year":"2003","journal-title":"BMJ"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"KF Schulz","year":"1995","journal-title":"JAMA"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"M Egger","year":"1997","journal-title":"BMJ"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1056\/NEJMoa031633","article-title":"Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis","volume":"350","author":"GA Block","year":"2004","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1046\/j.1523-1755.2000.00183.x","article-title":"A calcimimetic agent lowers plasma parathyroid hormone levels in patients with secondary hyperparathyroidism","volume":"58","author":"WG Goodman","year":"2000","journal-title":"Kidney Int"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1681\/ASN.V1341017","article-title":"The Calcimimetic agent AMG 073 lowers plasma parathyroid hormone levels in hemodialysis patients with secondary hyperparathyroidism","volume":"13","author":"WG Goodman","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1053\/j.ajkd.2004.08.029","article-title":"Pharmacokinetics, pharmacodynamics, and safety of cinacalcet hydrochloride in hemodialysis patients at doses up to 200 mg once daily","volume":"44","author":"RZ Harris","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1046\/j.1523-1755.2003.00720.x","article-title":"The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism","volume":"63","author":"JS Lindberg","year":"2003","journal-title":"Kidney Int"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1681\/ASN.2004060512","article-title":"Cinacalcet HCl, an oral calcimimetic agent for the treatment of secondary hyperparathyroidism in hemodialysis and peritoneal dialysis: a randomized, double-blind, multicenter study","volume":"16","author":"JS Lindberg","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/01.ASN.0000050224.03126.AD","article-title":"The calcimimetic AMG 073 as a potential treatment for secondary hyperparathyroidism of end-stage renal disease","volume":"14","author":"LD Quarles","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1093\/ndt\/gfm534","article-title":"Cinacalcet (KRN1493) effectively decreases the serum intact PTH level with favorable control of the serum phosphorus and calcium levels in Japanese dialysis patients","volume":"23","author":"M Fukagawa","year":"2008","journal-title":"Nephrol Dial Transplant"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1744-9987.2008.00556.x","article-title":"Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism","volume":"12","author":"T Akiba","year":"2008","journal-title":"Ther Apher Dial"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1111\/j.1523-1755.2005.00517.x","article-title":"First- and second-generation immunometric PTH assays during treatment of hyperparathyroidism with cinacalcet HCl","volume":"68","author":"KJ Martin","year":"2005","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.03591006","article-title":"The OPTIMA study: assessing a new cinacalcet (Sensipar\/Mimpara) treatment algorithm for secondary hyperparathyroidism","volume":"3","author":"P Messa","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.5414\/CNP68010","article-title":"Cinacalcet HCI (Sensipar\/Mimpara) is an effective chronic therapy for hemodialysis patients with secondary hyperparathyroidism","volume":"68","author":"JR Sterrett","year":"2007","journal-title":"Clin Nephrol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"269","DOI":"10.5414\/CNP69269","article-title":"An assessment of cinacalcet HCl effects on bone histology in dialysis patients with secondary hyperparathyroidism","volume":"69","author":"HH Malluche","year":"2008","journal-title":"Clin Nephrol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/ndt\/gfq725","article-title":"The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis","volume":"26","author":"P Raggi","year":"2011","journal-title":"Nephrol Dial Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.2215\/CJN.01040308","article-title":"Cinacalcet HCl and concurrent low-dose vitamin D improves treatment of secondary hyperparathyroidism in dialysis patients compared with vitamin D alone: the ACHIEVE study results","volume":"3","author":"S Fishbane","year":"2008","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"c41","DOI":"10.1159\/000212102","article-title":"Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet","volume":"112","author":"M Wilkie","year":"2009","journal-title":"Nephron Clin Pract"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1093\/ndt\/gfp762","article-title":"Study design and subject baseline characteristics in the ADVANCE Study: effects of cinacalcet on vascular calcification in haemodialysis patients","volume":"25","author":"J Floege","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1053\/j.ajkd.2010.07.012","article-title":"Economic analysis of cinacalcet in combination with low-dose vitamin D versus flexible-dose vitamin D in treating secondary hyperparathyroidism in hemodialysis patients","volume":"56","author":"TI Shireman","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"110","DOI":"10.2215\/CJN.03630509","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","volume":"5","author":"JB Wetmore","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF02411252","article-title":"Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function","volume":"34","author":"C Minkin","year":"1982","journal-title":"Calcif Tissue Int"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/ndt\/13.suppl_3.29","article-title":"Biochemical markers of bone turnover in the diagnosis of renal osteodystrophy: what do we have, what do we need?","volume":"13","author":"A Ferreira","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1681\/ASN.V73506","article-title":"Plasma total versus bone alkaline phosphatase as markers of bone turnover in hemodialysis patients","volume":"7","author":"P Urena","year":"1996","journal-title":"J Am Soc Nephrol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1172\/JCI119851","article-title":"The calcimimetic compound NPS R-568 suppresses parathyroid cell proliferation in rats with renal insufficiency. Control of parathyroid cell growth via a calcium receptor","volume":"100","author":"M Wada","year":"1997","journal-title":"J Clin Invest"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","article-title":"NPS R-568 halts or reverses osteitis fibrosa in uremic rats","volume":"53(2)","author":"M Wada","year":"1998","journal-title":"Kidney Int"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"Salgueira M, del Toro N, Moreno-Alba R, Jimenez E, Areste N, <etal>et al<\/etal>.. (2003) Vascular calcification in the uremic patient: a cardiovascular risk? Kidney Int Suppl: S119\u2013121.","DOI":"10.1046\/j.1523-1755.63.s85.28.x"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1242\/jeb.184.1.89","article-title":"Calcium handling by the mammalian kidney","volume":"184","author":"RJ Bindels","year":"1993","journal-title":"J Exp Biol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0048070","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,30]],"date-time":"2022-01-30T14:56:42Z","timestamp":1643554602000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0048070"}},"subtitle":[],"editor":[{"given":"Emmanuel A.","family":"Burdmann","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,10,25]]},"references-count":41,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2012,10,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0048070","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,10,25]]}}}